Published Technical Disclosure Archive

Personalized Blood Treatment System with Integrated AI, IoT, and Blockchain Technologies

Publication ID: 24-11857711_0008_PTD
Published: October 28, 2025
Category:Synergistic Combinations

Legal Citation

pr1or.art Inc., “Personalized Blood Treatment System with Integrated AI, IoT, and Blockchain Technologies,” Published Technical Disclosure No. 24-11857711_0008_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857711_0008_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,711.

Summary of the Inventive Concept

The disclosed inventive concept integrates a blood treatment apparatus with AI, IoT, and blockchain technologies to create a personalized, real-time optimized, and secure blood treatment system.

Background and Problem Solved

The original patent, related to a method for setting a control device or a closed-loop control device of a blood treatment apparatus, had limitations in terms of real-time optimization, patient data management, and supply chain security. The new inventive concept addresses these limitations by integrating AI-driven treatment optimization, IoT-enabled sensor networks, and blockchain-based patient data management and supply chain management.

Detailed Description of the Inventive Concept

The inventive concept comprises a blood treatment apparatus, an AI-driven treatment optimization module, an IoT-enabled sensor network, and a blockchain-based patient data management system. The AI module dynamically adjusts treatment parameters based on real-time patient data and medical research updates. The IoT sensor network provides real-time monitoring of treatment parameters, which are analyzed by the AI analytics engine. The blockchain system ensures secure storage and sharing of patient health data, as well as authenticity and quality of dialysis liquid supplies.

Novelty and Inventive Step

The new claims introduce the synergistic combination of AI, IoT, and blockchain technologies with a blood treatment apparatus, enabling real-time optimization, secure patient data management, and supply chain security. This integration is non-obvious and novel compared to the original patent.

Alternative Embodiments and Variations

Alternative embodiments could include integrating the AI module with other medical devices, using different blockchain platforms, or incorporating additional IoT sensors. Variations could include adapting the system for different blood treatment modalities or incorporating additional features such as telemedicine or remote monitoring.

Potential Commercial Applications and Market

The inventive concept has significant commercial potential in the medical device and healthcare industries, particularly in the areas of personalized medicine, telemedicine, and supply chain management. The system could be marketed to hospitals, clinics, and dialysis centers, as well as to patients and caregivers seeking more effective and convenient blood treatment options.

CPC Classifications

SectionClassGroup
A A61 A61M1/1601
A A61 A61M1/28
A A61 A61M1/34
A A61 A61M60/113
A A61 A61M2205/3334

Field of Art

Medical Device Technology, Specifically Blood Treatment Apparatus and Control Systems, involving Complex Medical Equipment Design, Sensor Integration, and Treatment Parameter Management

Person of Ordinary Skill (PHOSITA) Profile

A biomedical engineer with advanced degree, expertise in medical device design, familiarity with control systems, sensor technologies, data analytics, and regulatory compliance for medical equipment

Obviousness Rationale

A PHOSITA would recognize that integrating AI, IoT, and blockchain technologies into blood treatment systems represents a predictable technological evolution, leveraging known techniques to enhance monitoring, data management, and treatment optimization. The fundamental blood treatment apparatus architecture remains consistent, with the PTD introducing incremental technological improvements using standard engineering approaches. These variations represent logical extensions of existing medical device technological trends, applying well-established computational and networking technologies to enhance medical device functionality.

Obvious Combinations & Variations

Source Patent Element
Blood treatment apparatus with flow control and parameter adjustment mechanisms
PTD Variation
AI-driven treatment optimization module dynamically adjusting treatment parameters
Obviousness Reasoning
Predictable application of machine learning to existing parameter adjustment techniques, representing a known approach to enhancing medical device performance through computational intelligence
Source Patent Element
Extracorporeal blood circuit with pump and control systems
PTD Variation
IoT-enabled sensor network for real-time monitoring of treatment parameters
Obviousness Reasoning
Standard engineering practice of integrating advanced sensor technologies to improve medical device monitoring and data collection capabilities
Source Patent Element
Dialysis liquid management system
PTD Variation
Blockchain-based supply chain management for ensuring dialysis liquid authenticity
Obviousness Reasoning
Logical application of blockchain verification technologies to address quality control and traceability challenges in medical supply chains
Source Patent Element
Control device with user input for treatment parameter adjustment
PTD Variation
Machine learning-based predictive maintenance module for detecting potential equipment failures
Obviousness Reasoning
Predictable extension of existing parameter monitoring techniques using advanced computational diagnostics and failure prediction algorithms
Source Patent Element
Blood treatment apparatus with configurable treatment parameters
PTD Variation
Telemedicine platform with AI-driven patient support and remote consultation
Obviousness Reasoning
Natural technological progression integrating remote monitoring and computational guidance into existing medical device ecosystems
35 U.S.C. § 103 Summary: Based on the teachings of US Patent 11857711 and the technological context of medical device design, the variations disclosed herein would be considered obvious to a Person Having Ordinary Skill In The Art, representing predictable applications of known computational, networking, and sensor technologies to existing blood treatment apparatus architectures. The incremental technological improvements demonstrate no inventive step beyond the ordinary capabilities of skilled practitioners in medical device engineering and computational health technologies.

Original Patent Information

Patent NumberUS 11,857,711
TitleMethod for setting a control device or a closed-loop control device of a blood treatment apparatus, and devices
Assignee(s)Fresenius Medical Care Deutschland GmbH